Research assistance

We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 

Matching geography

Reports matching your search in:
 
 

Start new browse

 
 

Join Alert Me now!

Receive bi-weekly email alerts on new market research

Sign up today!
 

Therapeutic Area: market research reports

1594

A Therapeutic area refers to specific category of diseases or conditions for which there are known medical treatments or promising treatments in development. It is a way to classify drugs without reference to the type of therapy, form of action or the company that makes it, but instead to look at the the disease it treats and what other treatments complete. For some therapeutic areas, there are few drug products, while development is robust in other areas.
For instance, cardiology would be a therapeutic area and various drugs – beta blockers and antihyperlipidemic agents would be included in this therapeutic area. Another category which could be classified as a therapeutic area would be CNS/Neurology, Diabetes, or Anti Inflammatory Diseases. Other therapeutics areas would include Dermatology, Psychotherapy, Urology and Travel Medicine.

Reports in these categories will contain statistics of prevalence and growth on the revalvent diseases for which there are therapeutics, product reviews, market size and share for products that are used in pharmaceutical treatment, and market size and market share for products or equipment that would be used in surgical treatment of the therapeutic area.

RSS Feeds

Therapeutic Area market research reports and industry analysis

< prev 1  2  3  4  5  6  7  8  9  10  next >
Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and Indications (Oncology/Cardiology/Neurology) – Forecasts from 2012 to 2017
1/14/2013 | published by: MarketsandMarkets
... science is evolving for analyzing the basic metabolic changes taking place in a living organism. Metabolomics is thus an emerging concept which refers to the systematic study of the distinctive chemical fingerprints generated in a ...  |  more...
Search inside this report
$4,650.00
Triple Analysis: Leukemia, Lung Cancer and Peptides
1/7/2013 | published by: BioSeeker Group AB
... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ...  |  more...
$5,175.00
Triple Analysis: Lymphoma, Protein Kinase Inhibitors and Peptides
1/7/2013 | published by: BioSeeker Group AB
... according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus ...  |  more...
$5,175.00
Triple Analysis: Breast Cancer, Protein Kinase Inhibitors and Peptides
1/7/2013 | published by: BioSeeker Group AB
... evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer ...  |  more...
$5,175.00
Triple Analysis: Breast Cancer, Colorectal Cancer and Peptides
1/7/2013 | published by: BioSeeker Group AB
... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ...  |  more...
$5,175.00
Triple Analysis: Breast Cancer, Antibodies and Peptides
1/7/2013 | published by: BioSeeker Group AB
... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ...  |  more...
$5,175.00
Triple Analysis: Pancreatic Cancer, Protein Kinase Inhibitors and Peptides
1/7/2013 | published by: BioSeeker Group AB
... evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer ...  |  more...
$5,175.00
Triple Analysis: Colorectal Cancer, Leukemia and Peptides
1/7/2013 | published by: BioSeeker Group AB
... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ...  |  more...
$5,175.00
Triple Analysis: Colorectal Cancer, Prostate Cancer and Peptides
1/7/2013 | published by: BioSeeker Group AB
... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ...  |  more...
$5,175.00
Triple Analysis: Breast Cancer, Lymphoma and Peptides
1/7/2013 | published by: BioSeeker Group AB
... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ...  |  more...
$5,175.00
Triple Analysis: Breast Cancer, Pancreatic Cancer and Peptides
1/7/2013 | published by: BioSeeker Group AB
... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ...  |  more...
$5,175.00
Triple Analysis: Angiogenesis, Protein Kinase Inhibitors and Peptides
1/7/2013 | published by: BioSeeker Group AB
... according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus ...  |  more...
$5,175.00
Triple Analysis: Prostate Cancer, Angiogenesis and Peptides
1/7/2013 | published by: BioSeeker Group AB
... to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area ...  |  more...
$5,175.00
Analytical Tool - Antibodies and Peptides in Oncology
1/7/2013 | published by: BioSeeker Group AB
... competitive landscape. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product ...  |  more...
$8,925.00
Triple Analysis: Leukemia, Pancreatic Cancer and Peptides
1/7/2013 | published by: BioSeeker Group AB
... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ...  |  more...
$5,175.00
Triple Analysis: Prostate Cancer, Cancer Vaccines and Peptides
1/7/2013 | published by: BioSeeker Group AB
... according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus ...  |  more...
$5,175.00
Triple Analysis: Leukemia, Apoptosis and Peptides
1/7/2013 | published by: BioSeeker Group AB
... standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but ...  |  more...
$5,175.00
Triple Analysis: Prostate Cancer, Protein Kinase Inhibitors and Peptides
1/7/2013 | published by: BioSeeker Group AB
... evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer ...  |  more...
$5,175.00
Triple Analysis: Pancreatic Cancer, Prostate Cancer and Peptides
1/7/2013 | published by: BioSeeker Group AB
... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ...  |  more...
$5,175.00
Triple Analysis: Pancreatic Cancer, Antibodies and Peptides
1/7/2013 | published by: BioSeeker Group AB
... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ...  |  more...
$5,175.00
Triple Analysis: Lung Cancer, Apoptosis and Peptides
1/7/2013 | published by: BioSeeker Group AB
... to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area ...  |  more...
$5,175.00
Triple Analysis: Prostate Cancer, Apoptosis and Peptides
1/7/2013 | published by: BioSeeker Group AB
... to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area ...  |  more...
$5,175.00
Triple Analysis: Prostate Cancer, Antibodies and Peptides
1/7/2013 | published by: BioSeeker Group AB
... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ...  |  more...
$5,175.00
Triple Analysis: Apoptosis, Angiogenesis and Peptides
1/7/2013 | published by: BioSeeker Group AB
... standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but ...  |  more...
$5,175.00
Triple Analysis: Lymphoma, Prostate Cancer and Peptides
1/7/2013 | published by: BioSeeker Group AB
... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ...  |  more...
$5,175.00
< prev 1  2  3  4  5  6  7  8  9  10  next >